JAZZ vs PEG · P/E 1988, rev $4.07B vs P/E 18, rev $10.29B
Jazz Pharmaceuticals PLC (JAZZ) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the JAZZ and PEG stock pages for the full models.
Not investment advice.